Ardelyx, Inc. (ARDX) stock
ARDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3059% below fair value
$3.12−0.06 (-1.89%)
Close on Nov 18, 2026Market cap $777.47MP/E –Yield –
Ardelyx shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Ardelyx's shares outstanding was 248M at Jun 30, 2026. For fiscal 2025 it was 241M, up 2.5% from the year before. Over ten years it grew 26.5% a year on average. The highest annual figure on record is 241M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 241M | +2.5% |
| FY2024 | Dec 31, 2024 | 235M | +7.3% |
| FY2023 | Dec 31, 2023 | 219M | +38.2% |
| FY2022 | Dec 31, 2022 | 159M | +52.3% |
| FY2021 | Dec 31, 2021 | 104M | +16.3% |
| FY2020 | Dec 31, 2020 | 90M | +38.9% |
| FY2019 | Dec 31, 2019 | 64M | +14.7% |
| FY2018 | Dec 31, 2018 | 56M | +18.5% |
| FY2017 | Dec 31, 2017 | 47M | +18.2% |
| FY2016 | Dec 31, 2016 | 40M | +75.2% |
| FY2015 | Dec 31, 2015 | 23M | +123.4% |
| FY2014 | Dec 31, 2014 | 10M | +808.6% |
| FY2013 | Dec 31, 2013 | 1M | +30.5% |
| FY2012 | Dec 31, 2012 | 1M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 248M | +3.4% |
| Q1 FY2026 | Mar 31, 2026 | 246M | +3.0% |
| Q4 FY2025 | Dec 31, 2025 | 244M | +2.6% |
| Q3 FY2025 | Sep 30, 2025 | 242M | +2.5% |
| Q2 FY2025 | Jun 30, 2025 | 240M | +2.3% |
| Q1 FY2025 | Mar 31, 2025 | 239M | +2.4% |
| Q4 FY2024 | Dec 31, 2024 | 237M | +2.1% |
| Q3 FY2024 | Sep 30, 2024 | 236M | +3.5% |
| Q2 FY2024 | Jun 30, 2024 | 235M | +9.1% |
| Q1 FY2024 | Mar 31, 2024 | 233M | +12.6% |
| Q4 FY2023 | Dec 31, 2023 | 232M | +20.5% |
| Q3 FY2023 | Sep 30, 2023 | 228M | +38.0% |
| Q2 FY2023 | Jun 30, 2023 | 215M | +47.7% |
| Q1 FY2023 | Mar 31, 2023 | 207M | +58.1% |
| Q4 FY2022 | Dec 31, 2022 | 193M | +67.1% |
| Q3 FY2022 | Sep 30, 2022 | 165M | +58.5% |
| Q2 FY2022 | Jun 30, 2022 | 146M | +45.5% |
| Q1 FY2022 | Mar 31, 2022 | 131M | +34.7% |
| Q4 FY2021 | Dec 31, 2021 | 115M | +26.8% |
| Q3 FY2021 | Sep 30, 2021 | 104M | +16.5% |
| Q2 FY2021 | Jun 30, 2021 | 100M | +12.3% |
| Q1 FY2021 | Mar 31, 2021 | 97M | +9.3% |
| Q4 FY2020 | Dec 31, 2020 | 91M | +30.2% |
| Q3 FY2020 | Sep 30, 2020 | 89M | +42.2% |
| Q2 FY2020 | Jun 30, 2020 | 89M | +42.2% |
| Q1 FY2020 | Mar 31, 2020 | 89M | +42.1% |
| Q4 FY2019 | Dec 31, 2019 | 70M | +12.2% |
| Q3 FY2019 | Sep 30, 2019 | 63M | +1.2% |
| Q2 FY2019 | Jun 30, 2019 | 63M | +18.6% |
| Q1 FY2019 | Mar 31, 2019 | 63M | +31.5% |
| Q4 FY2018 | Dec 31, 2018 | 62M | +31.0% |
| Q3 FY2018 | Sep 30, 2018 | 62M | +30.8% |
| Q2 FY2018 | Jun 30, 2018 | 53M | +11.4% |
| Q1 FY2018 | Mar 31, 2018 | 48M | +0.5% |
| Q4 FY2017 | Dec 31, 2017 | 48M | +0.4% |
| Q3 FY2017 | Sep 30, 2017 | 47M | +5.6% |
| Q2 FY2017 | Jun 30, 2017 | 47M | – |
| Q1 FY2017 | Mar 31, 2017 | 47M | – |
| Q4 FY2016 | Dec 31, 2016 | 47M | – |
| Q3 FY2016 | Sep 30, 2016 | 45M | – |
See a number that looks wrong?